Delivery Order SPE2DB24D1205-SPE2DB25FCWLH

Award Date 5/5/25
Potential Completion Date 5/27/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Orgovyx (relugolix) 120 mg tablets. The contract has a ceiling value of $4,156.56 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx (relugolix) 120 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,385.52, is for the delivery of the medication Orgovyx (relugolix) 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Orgovyx (relugolix) 120 mg tablets. The contract has a ceiling value of $13,298.90 and a period of performance through October 17, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Orgovyx tablets to support military treatment facilities and other...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Orgovyx (relugolix) 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,626.24 and a period of performance through April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is a delivery order for the medication Orgovyx (relugolix) 120 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.56 fixed-price delivery order is for the drug Orgovyx (relugolix) 120 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price contract is for the supply of 120 mg ORGOVYX (relugolix) tablets. ORGOVYX is a medication used to treat advanced prostate cancer. The contract has an ultimate completion date of April 29, 2025 and is not a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug Orgovyx (relugolix) 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,649.45 and a performance period through August 2024. The award does not utilize a socioeconomic set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Orgovyx 120 mg tablet. The contract has a ceiling value of $1,385.52 and a period of performance through April 28, 2025. This contract is not designated as a set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWLH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx (relugolix) 120 mg tablets. The contract is a firm fixed-price delivery order, with a performance period ending on May 27, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 8/4/25, 9:56 AM